PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 182.50
Bid: 175.00
Ask: 190.00
Change: 0.00 (0.00%)
Spread: 15.00 (8.571%)
Open: 182.50
High: 182.50
Low: 182.50
Prev. Close: 182.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

29 Sep 2020 07:00

RNS Number : 3448A
Synectics PLC
29 September 2020
 

 

 

 

 

29 September 2020

 

 

Synectics plc

("Synectics" or the "Company" or the "Group")

 

Trading Update

 

Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, provides the following update on trading.

 

The global Covid-19 pandemic has continued to impact activity across all of Synectics' markets, but has particularly affected its largest market sector, global casinos and gaming, where the recovery in the second half of the Company's financial year is now unlikely to take place as previously expected.

 

Trading and forecasts in other sectors of the Group's business have, in aggregate, remained largely in line with the Board's previous expectations. However, the ongoing interruption to gaming activity around the world means that consolidated revenues and underlying results in the second half of the Group's financial year to 30 November 2020 are now likely to be lower than those in the first half.

 

The Company had expected that easing of travel restrictions and the re-opening in early summer of casinos in the US and Asia would result in some recovery during the second half of this year. However, it has become increasingly evident that the vast majority of planned surveillance system projects and upgrades in this sector will now be delayed beyond 2020.

 

Progress on the large and strategically important command and control system contract for the Berlin S-Bahn has been good. The first two customer milestones have been met and the project is on track for live operation in January 2021. This project incorporates the next generation of Synectics' core Synergy software platform, with capabilities applicable to a significantly larger and higher-level potential market in the public transport and infrastructure sector than Synergy has previously addressed. Levels of current bid activity and interest from customers and prospective global IT integrator partners continue to suggest that both the market opportunity and the competitive environment are favourable for the new Synergy offering.

 

Work is progressing as planned to consolidate the operations of Synectics' Integration and Managed Services division, as reported in the Company's interim statement on 14 July 2020. This consolidation includes the closure or downsizing of several operating sites, with a consequent reduction in costs and sharpened focus on specialised and long-term customers for whom Synectics can provide a valuable differentiated service. The new combined business, "Synectics Security", launched in September has been well received. The consolidation will be completed by the end of this financial year.

 

Given the increased uncertainty in the timing of market recovery from Covid impacts, management's forecasts and plans are now based on the assumption that demand in affected sectors will remain weak for some time to come.

 

Synectics' priorities continue to be: to protect the health and well-being of its employees and customers; to provide ongoing support to its customers; and to manage the business for the long term by prudent actions to preserve cash and maintain the employee skill base essential to develop, sell, deliver and support its core technology and services.

 

Much attention is being paid to balancing and securing these objectives.

 

The Group's net cash balance as at 31 August 2020 was £7.3 million (31 May 2020: £4.6 million), with additional undrawn bank facilities of £5 million. This increased cash results largely from lower working capital needed to support reduced revenues, a position that will unwind, at least in part, as revenues recover to more normal levels.

 

The Company will issue a further trading update in early December following its year end.

 

Paul Webb, Chief Executive of Synectics, commented:

 

"With our ongoing investment in advanced product development and deep customer relationships, Synectics is well positioned across our global markets for long-term success. Given the impact of Covid-19 across many of the sectors we work in, our focus has been to support our customers and people, while acknowledging the inevitable impact this has had on our short-term trading and financial performance.

 

"We remain confident in our long-term growth prospects as our software and technology capabilities continue to open up new opportunities in evolving markets for our security and surveillance technology."

 

Ends

 

About Synectics plc

 

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

 

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The group's expert engineering teams work in partnership with customers to create integrated product and technology platforms, proven in the most complex and demanding operating environments.

 

Find out more at www.synecticsplc.com.

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850 080

Paul Webb, Chief Executive

 

David Coghlan, Chairman

David Bedford, Finance Director

 

email: info@synecticsplc.com

www.synecticsplc.com

 

 

Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / Henry Willcocks / David Coaten

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZGZLKRDGGZM
Date   Source Headline
16th Jun 20097:00 amRNSStructural and Strategic Reorganisation
4th Feb 20097:00 amRNSInterim Results
16th Jan 200912:06 pmRNSNotification of Results
3rd Sep 20087:00 amRNSPreliminary Results
6th Feb 20087:01 amRNSInterim Results
16th Jan 20087:00 amRNSNotification of Results
6th Dec 20071:09 pmRNSCanc of AIM trading facility
6th Dec 20079:56 amRNSOffer Update
30th Nov 20077:01 amRNSOffer Update
29th Nov 20077:01 amRNSOffer Update
26th Nov 200712:34 pmRNSResult of EGM
23rd Nov 20079:57 amRNSRule 8.1- Synexus
19th Nov 20079:40 amRNSRule 8.1- Synexus
16th Nov 200710:00 amRNSRule 8.1- Synexus
15th Nov 20073:00 pmBUSRule 8.3 - Synexus Clinincal Research Plc
15th Nov 200712:07 pmBUSRule 8.3 - Synexus Clinical Research Plc
15th Nov 20079:16 amRNSRule 8.1- Synexus
14th Nov 20073:21 pmBUSRule 8.3 - Synexus Clinical Research Plc
13th Nov 20073:16 pmBUSRule 8.3 - Synexus Clinical Research Plc
7th Nov 20074:38 pmRNSOffer Document Posted
7th Nov 20077:02 amRNSOffer for Synexus
6th Nov 20079:10 amRNSRule 8.3- Synexus
22nd Oct 200710:46 amRNSHolding(s) in Company
19th Oct 20076:21 pmRNSResponse to price movement
28th Sep 20077:02 amRNSPre Close Statement
5th Sep 20078:33 amRNSBoard Change
5th Sep 20077:01 amRNSPreliminary Results
22nd Aug 20073:17 pmRNSHolding(s) in Company
22nd Aug 200711:19 amRNSAIM RULE 26
15th Jun 20071:26 pmRNSGrant of Options
13th Jun 20077:01 amRNSPreliminary Results
24th May 20074:24 pmRNSNotice of Results
8th Mar 20077:00 amRNSHolding(s) in Company
20th Feb 200712:33 pmRNSGrant of Options
7th Feb 20077:02 amRNSNorth American Contract Wins
7th Feb 20077:02 amRNSInterim Results
6th Feb 200710:14 amRNSDirector/PDMR Shareholding
5th Feb 20077:00 amRNSDirectorate Change
29th Jan 20072:58 pmRNSNotice of Results
26th Jan 20077:01 amRNSTrading Update
28th Dec 20064:36 pmRNSGrant of Options
22nd Dec 20069:37 amRNSTotal Voting Rights & Capital
5th Dec 20067:01 amRNSInterim Results
29th Nov 20063:25 pmRNSDirector/PDMR Shareholding
24th Nov 200611:53 amRNSNotice of Results
24th Oct 20067:01 amRNSAcquisition
4th Oct 20067:00 amRNSTrading Statement
18th Sep 20069:11 amRNSDirectorate Change
13th Jul 20067:01 amRNSIssue of Equity
20th Jun 200610:39 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.